{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:29:02Z","timestamp":1778660942678,"version":"3.51.4"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI69503-03S2"],"award-info":[{"award-number":["U01 AI69503-03S2"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["410722_GR410708"],"award-info":[{"award-number":["410722_GR410708"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI117970"],"award-info":[{"award-number":["AI117970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214820","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:13:08Z","timestamp":1554833588000},"page":"e0214820","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort"],"prefix":"10.1371","volume":"14","author":[{"given":"Kamwing","family":"Jair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chase D.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda D.","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"P\u00e9rez-Losada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Wilbourn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan E.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1859-1393","authenticated-orcid":true,"given":"Jeanne A.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the DC Cohort Executive Committee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12977-016-0321-6","article-title":"Ultrasensitive single genome sequencing: accurate, targeted next generation sequencing of HIV-1 RNA","volume":"13","author":"VF Boltz","year":"2016","journal-title":"Retrovirology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/jac\/dkx232","article-title":"RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-na\u00efve patients","volume":"72","author":"EK Alidjinou","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00038-16","article-title":"Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure","volume":"60","author":"F Kyeyune","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dku426","article-title":"Low-frequency drug-resistant HIV-1 and risk of virologic failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing","volume":"70","author":"A Cozzi-Lepri","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/QAD.0000000000000203","article-title":"HIV Drug Resistance Detected During Low-Level Viremia Is Associated with Subsequent Virologic Failure","volume":"28","author":"LC Swenson","year":"2014","journal-title":"AIDS"},{"issue":"13","key":"ref6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Minority HIV-1 Drug Resistance Mutations and the Risk of NNRTI-based Antiretroviral Treatment Failure: A Systematic Review and Pooled Analysis","volume":"305","author":"JZ Li","year":"2011","journal-title":"JAMA"},{"key":"ref7","year":"2017"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/infdis\/jir025","article-title":"Gatell, JM, Shafer RW. HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications","volume":"203","author":"JL Blanco","year":"2011","journal-title":"J Infect Dis"},{"key":"ref9","article-title":"HyDRA Web User Guide","author":"M Nykoluk","year":"2016","journal-title":"HyDRA Web User Guide"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation","volume":"42","author":"TF Liu","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"e27775","DOI":"10.1371\/journal.pone.0027775","article-title":"Using HIV Transmission Networks to Investigate Community Effects in HIV Prevention Trials","volume":"6","author":"JO Wertheim","year":"2011","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/jit524","article-title":"The Global Transmission Network of HIV-1","volume":"209","author":"JO Wertheim","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/aid.2016.0205","article-title":"Identifying transmission clusters with Cluster Picker and HIV-TRACE","volume":"33","author":"R Rose","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref14","article-title":"Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants","author":"M Perrier","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"e01443","DOI":"10.1128\/JCM.01443-18","article-title":"Limited marginal utility of deep sequencing for HIV drug resistance testing in the age of integrase inhibitors","volume":"56","author":"R Dalmat","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jamia\/ocv176","article-title":"Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions","volume":"23","author":"AE Greenberg","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/jac\/dkw109","article-title":"Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity","volume":"71","author":"K Anstett","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12977-018-0440-3","article-title":"Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir","volume":"15","author":"M Oliveira","year":"2018","journal-title":"Retrovirology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/ijerph15081697","article-title":"Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1","volume":"15","author":"A Arias","year":"2018","journal-title":"Virus in Blood Compartments. Int J Environ Res Public Health"},{"issue":"6","key":"ref20","first-page":"e00105","article-title":"Comparison of an <italic>In Vitro<\/italic> Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing","volume":"56","author":"PL Tzou","year":"2018"},{"key":"#cr-split#-ref21.1","unstructured":"1. Centers for Disease Control and Prevention. Detecting and Responding to HIV Transmission Clusters, A Guide For Health Departments. June 2018, DRAFT Version 2.0"},{"key":"#cr-split#-ref21.2","unstructured":"2. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/hiv\/pdf\/funding\/announcements\/ps18-1802\/CDC-HIV-PS18-1802-AttachmentE\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/hiv\/pdf\/funding\/announcements\/ps18-1802\/CDC-HIV-PS18-1802-AttachmentE<\/ext-link>."},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/S2352-3018(16)00046-1","article-title":"Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study","volume":"3","author":"AFY Poon","year":"2016","journal-title":"Lancet HIV"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","DOI":"10.3390\/v10010041","article-title":"Resistance to HIV Integrase Inhibitors: About R26K and E157Q Mutations","volume":"10","author":"C Charpentier","year":"2018","journal-title":"Viruses"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jac\/dkx511","article-title":"Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen","volume":"73","author":"C Charpentier","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.20.1.21846","article-title":"Comparison between next\u2010generation and Sanger\u2010based sequencing for the detection of transmitted drug\u2010resistance mutations among recently infected HIV\u20101 patients in Israel, 2000\u20132014","volume":"20","author":"R Moscona","year":"2017","journal-title":"JIAS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11908-014-0401-5","article-title":"Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?","volume":"16","author":"RM Gibson","year":"2014","journal-title":"Curr Infect Dis Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1016\/S2352-3018(16)30119-9","article-title":"Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey","volume":"3","author":"S Avila-R\u00edos","year":"2016","journal-title":"Lancet HIV"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2016.11.008","article-title":"A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing","volume":"240","author":"M Huber","year":"2017","journal-title":"J Virol Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/1570162033352110","article-title":"Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission","volume":"1","author":"JM Baeten","year":"2003","journal-title":"Curr HIV Res"},{"key":"ref30","first-page":"1000106","article-title":"Accuracy of Next Generation Sequencing Platforms","volume":"1","author":"EJ Fox","year":"2014","journal-title":"Accuracy of Next Generation Sequencing Platforms"},{"issue":"16","key":"ref31","first-page":"8540","article-title":"Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1","volume":"89","author":"S Zhou","year":"2015","journal-title":"Genomic RNA Populations. J Virol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s13104-017-2764-9","article-title":"Prevalence and Trends in Transmitted and Acquired Antiretroviral Drug Resistance in Washington, District of Columbia, 1999\u20132014","volume":"10","author":"A Aldous","journal-title":"BMC Res Notes 2017"},{"key":"ref33","article-title":"Characterization of HIV diversity, phylodynamics and drug resistance in Washington, DC","author":"M P\u00e9rez-Losada","year":"2017","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T16:04:38Z","timestamp":1663257878000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214820"}},"subtitle":[],"editor":[{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214820","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]}}}